More than a quarter of solid-organ transplant recipients are traveling to foreign regions where there are greater health risks than their home country. There may be higher risk of complications from typical travel-related illnesses and risk of opportunistic infections not faced by healthy travelers. Some vaccinations may be contraindicated after solid-organ transplant, and those that are safe may have decreased efficacy. Drug interactions between antirejection regimens and medications for malaria prophylaxis and traveler’s diarrhea must be considered. This article discusses how providers can best advise and help protect these high-risk travelers.
All Keywords